CC1=N[C@@](C)(COC(=O)[C@]2(C)N[C@](C)(CO)CO2)COC1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?